6.000
+0,00%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +76.1% | +41.7% | 3 / 3 | +0.6% | +4.84 pp | +0.15 pp | +3.6% | 0.04 | 13.14 | 1.589 | +0,6% | 5,6 | +76,1% | 13.14 | 21.89 | −40,0% |
| Pts | 12 | 8 | 12 | 0 | 12 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.000 (close price on 2026-10-19)EPS (TTM): 456,7
Financial charts
1.Revenue & growth
VND bn1.586Q2/26
1.Revenue & growth
VND bn1.586Q2/26
2.Profit & growth
VND bn8,24Q2/26
3.Profit mix (Penman)
VND bn26,1Q2/26
4.Margins & cost structure
%8.0%Q2/26
5.Returns & cash cycle
% · days-2.6%Q2/26
6.Earnings quality & cash
VND bn406Q2/26
7.Asset structure
VND bn1.864Q2/26
8.Funding & debt health
VND bn · times1.864Q2/26
9.Revenue backlog
VND bn22,3Q2/26
10.Valuation
times · %11,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %206Q2/26
Adjusted EPS growth, latest quarter
159%
Average adjusted EPS growth, 3 quarters
69.3%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26